F Dx Advisors, Inc. Ginkgo Bioworks Holdings, Inc. Transaction History

F Dx Advisors, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	BUY	$1.26 - $1.79 $14,214 - $20,192	11,281 Added 9.48%	130,233 $220,000
Q3 2023 Nov 02, 2023	BUY	$1.61 - $2.54 $22,110 - $34,881	13,733 Added 13.05%	118,952 $215,000
Q2 2023 Jul 17, 2023	BUY	$1.14 - $1.95 $56,326 - $96,347	49,409 Added 88.53%	105,219 $195,000
Q4 2022 Feb 09, 2023	BUY	$1.63 - $3.52 $9,242 - $19,958	5,670 Added 11.31%	55,810 $94,000
Q3 2022 Nov 10, 2022	BUY	$0.73 - $3.74 $1,611 - $8,257	2,208 Added 4.61%	50,140 $156,000
Q2 2022 Aug 03, 2022	BUY	$2.2 - $4.2 $23,542 - $44,944	10,701 Added 28.74%	47,932 $114,000
Q1 2022 May 03, 2022	BUY	$2.83 - $8.69 $105,363 - $323,537	37,231 New	37,231 $150,000

48.4M

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $9.25B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of F Dx Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on F Dx Advisors, Inc. with notifications on news.